ENYO Pharma
ENYO Pharma is a clinical stage Biotech with a unique drug discovery platform inspired by viruses.
Que fait ENYO Pharma ?
NYO Pharma is a clinical stage Biotech with a unique drug discovery platform inspired by viruses.
The company is conducting three Phase 2 with its lead compound Vonafexor (EYP001, a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.
Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreover be developed for various indications (metabolic diseases, oncology…).
ENYO Pharma en bref
- Secteur
- Bien Être
- Localisation
- Paris, France
- Site officiel
- enyopharma.com
Données entreprise
- Raison sociale
- ENYO PHARMA
- SIREN
- 799831011
- SIRET (siège)
- 799 831 011 00041
- RCS
- 799 831 011
- Création
- 02/01/2014
- Ville du siège
- Lyon
- Statut
- En activité
- Dirigeants
- Jeffrey Pilgram George, Jacky Pierre Michel Vonderscher, Timothy Michael Wright
Source : Données publiques des entreprises (INSEE, RNE) · vérifié le 30/09/2026
ENYO Pharma sur Les Pépites Tech
Auteur
Commentaires
NYO Pharma is a clinical stage Biotech with a unique drug discovery platform inspired by viruses.
The company is conducting three Phase 2 with its lead compound Vonafexor (EYP001, a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.
Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreover be developed for various indications (metabolic diseases, oncology…).
Compte Officiel #LPT , Orpailleur de Pépites French Tech 13/04/2021 - 12:07
Startups similaires
Questions fréquentes
- Qu'est-ce que ENYO Pharma ?
- ENYO Pharma is a clinical stage Biotech with a unique drug discovery platform inspired by viruses.
- Où est basée ENYO Pharma ?
- Paris, France
- Dans quel secteur intervient ENYO Pharma ?
- Bien Être
- Quand ENYO Pharma a-t-elle été créée ?
- 02/01/2014
Publicité
Orpailleur de Pépites French Tech